Clinical trial
Randomized Trial of Mini-dose Methotrexate Plus Standard-dose Steroid vs Steroids for the Initial Treatment of Acute Graft Versus Host Disease
NCT05921305 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial of Mini-dose Methotrexate Plus Standard-dose Steroid vs Steroids for the Initial Treatment of Acute Graft Versus Host Disease
- Lead sponsor
- Peking University People's Hospital
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- August 3, 2023
- Completion date
- September 30, 2026
- Enrollment
- 218 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute graft versus host disease